TRAP1 knockout dramatically reduced retinal pathogenesis in mouse retinopathy models in vivo, and TRAP1 inhibitors reduced aberrant vascular changes in the retinopathy mice, identifying TRAP1 inhibitors as a potent treatment for ischemic retinal diseases. The gene discussed is TRAP1; the disease is retinal disorder.